Kathryn E. Falberg - May 15, 2023 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Director
Signature
Kathryn E. Falberg, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
NUVB
Transactions as of
May 15, 2023
Transactions value $
$0
Form type
4
Date filed
5/17/2023, 05:13 PM
Previous filing
Feb 9, 2023
Next filing
May 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +367K $0.00 367K May 15, 2023 Class A Common Stock 367K $1.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 15, 2024); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.